Australia, Aug. 5 -- Madrigal Pharmaceuticals Inc., owns the trademark (2519380) for 'REZDIFFRA' till Dec. 27, 2034.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis.]
Type of Mark: Word
Date of Acceptance: April 4
Registration Advertised: Aug. 4
For further details contact Anita B. Polott Morgan, Lewis & Bockius LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2519380.
Disclaimer: Curated by HT Syndication....